LipimetiX Development LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Joint Venture
- Established
- 2012-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.lipimetix.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia
Phase 1
Completed
- Conditions
- HypercholesterolemiaHyperlipoproteinemia Type II
- Interventions
- Drug: Normal Saline
- First Posted Date
- 2014-04-01
- Last Posted Date
- 2015-12-29
- Lead Sponsor
- LipimetiX Development, LLC
- Target Recruit Count
- 52
- Registration Number
- NCT02100839
- Locations
- 🇦🇺
Linear Clinical Research Ltd., Nedlands, Western Australia, Australia
News
No news found